CDE Catalog | NINDS Common Data Elements

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Subdomain Name

CRF Name

Displaying 26 - 50 of 740

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

Operations

Selected 25 rows in this page.

The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
Select all	CDE ID	CDE Name	Definition	Classification	CRF Name	Copyrighted or trademarked	Disease Name	Subdisease Name
F0004-C01581	C01581	Weight unit of measure	Unit of measure for the weight numerical value	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C01582	C01582	Height unit of measure	Unit of measure for the height numerical value for participant	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C02307	C02307	Adverse event verbatim term text	Text that describes the adverse event word for word as described by the participant/subject	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C02309	C02309	Serious adverse event indicator	The indicator of whether the adverse event is serious.	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C02310	C02310	Adverse event CTCAE low level term name	Text that represents the Common Terminology Criteria for Adverse Events (CTCAE) low level term name for an adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C02311	C02311	Adverse event MedDRA lower level term code	Code that corresponds to the Medical Dictionary for Regulatory Activities (MedDRA) Lower Level Term (LLT) for an adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C04802	C04802	Death date and time	Date (and time, if known) of participant's/subject's death	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C12232	C12232	Laboratory director name	Name of laboratory director where assessment was performed	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C17447	C17447	Event description text	The free-text field to describe the event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C18659	C18659	Unexpected adverse event indicator	The indicator of whether the adverse event is unexpected	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C19256	C19256	Study protocol name	Name of study protocol	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20391	C20391	Sex type	The sex of the subject/participant	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20392	C20392	Serious adverse event treatment description text	The text that describes the interventions specific to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20393	C20393	Serious adverse event start date and time	Date (and time, if applicable and known) on which the serious adverse event was first evident	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20394	C20394	Serious adverse event end date and time	Date (and time, if applicable and known) on which the serious adverse event discontinued/stopped	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20395	C20395	Serious adverse event laboratory data text	The text that describes the relevant tests or laboratory data specific to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20396	C20396	Serious adverse event concomitant medications text	The text that describes the concomitant medications taken	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20397	C20397	Serious adverse event relevant history text	The text that describes relevant history including pre-existing medical conditions	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20398	C20398	Serious adverse event medication administration text	The free-text field to describe the administration of study intervention	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20399	C20399	Serious averse event end treatment indicator	Indicate whether the study was discontinued due to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20400	C20400	Serious adverse event resolution indicator	Indicator to ask whether an adverse event ended after treatment with the study protocol drug or agent was stopped	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20401	C20401	Serious adverse event reappearance indicator	Indicate whether the adverse event reappeared after the treatment was restarted	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20402	C20402	Serious adverse event blind broken indicator	Indicate whether the study blind was broken	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20403	C20403	Serious adverse event investigator assessment	Indicate the principal investigator's opinion of the cause of the event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20404	C20404	Investigator assessment concurrent disorder specify text	The free-text field to specify the concurrent disorder that might have caused the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)

Displaying 26 - 50 of 740

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.